|
Aurobindo Pharma Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
74516.85 Cr.
|
P/BV
|
2.07
|
Book Value (Rs.)
|
618.98
|
|
52 Week High/Low (Rs.)
|
1320/1010
|
FV/ML
|
1/1
|
P/E(X)
|
21.38
|
|
Bookclosure
|
08/08/2025
|
EPS (Rs.)
|
60.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 24633.24 | 23106.38 | 21212.58 | 18238.46 | 17571.21 |
| Other Operating Income | 166.50 | 235.23 | 209.14 | 143.96 | 74.91 |
| Total Income From Operations | 24799.74 | 23341.61 | 21421.72 | 18382.42 | 17646.12 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 7799.84 | 7937.25 | 8141.26 | 6981.94 | 5467.41 |
| Purchase of Traded Goods | 2546.50 | 2250.93 | 1986.98 | 1461.68 | 1468.69 |
| Increase/Decrease in Stocks | -287.05 | -589.82 | -586.22 | -81.33 | 679.98 |
| Employees Cost | 3816.19 | 3312.98 | 2896.62 | 2670.35 | 2597.69 |
| Depreciation | 1299.62 | 1204.99 | 1167.33 | 899.01 | 872.95 |
| Other Expenses | 5869.79 | 5666.58 | 4827.17 | 4655.97 | 4019.98 |
| Total Expenses | 21044.89 | 19782.91 | 18433.14 | 16587.62 | 15106.70 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 3754.85 | 3558.70 | 2988.58 | 1794.80 | 2539.42 |
| Other Income | 413.53 | 514.22 | 436.04 | 178.33 | 271.47 |
| P/L Before Interest, Excpt. Items & Tax | 4168.38 | 4072.92 | 3424.62 | 1973.13 | 2810.89 |
| Interest | 285.76 | 342.22 | 200.28 | 84.88 | 39.43 |
| P/L Before Exceptional Items & Tax | 3882.62 | 3730.70 | 3224.34 | 1888.25 | 2771.46 |
| Exceptional Items | -65.33 | 0.00 | -69.75 | 0.00 | 34.79 |
| P/L Before Tax | 3817.29 | 3730.70 | 3154.59 | 1888.25 | 2806.25 |
| Tax | 1239.11 | 1150.46 | 888.47 | 460.70 | 708.14 |
| P/L After Tax from Ordinary Activities | 2578.18 | 2580.24 | 2266.12 | 1427.55 | 2098.11 |
| Net Profit/Loss For the Period | 2578.18 | 2580.24 | 2266.12 | 1427.55 | 2098.11 |
| Share Of P/L Of Associates | 3.95 | 0.50 | -4.50 | -5.81 | -27.14 |
| Net P/L After Minority Interest & Share Of Associates | 2582.13 | 2580.74 | 2261.62 | 1421.74 | 2070.97 |
| | | | | | |
| Equity Share Capital | 58.08 | 58.08 | 58.59 | 58.59 | 58.59 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 44.39 | 44.43 | 38.60 | 24.26 | 35.36 |
| Diluted EPS (Rs.) | 44.39 | 44.43 | 38.60 | 24.26 | 35.36 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 44.39 | 44.43 | 38.60 | 24.26 | 35.36 |
| Diluted EPS (Rs.) | 44.46 | 44.43 | 38.60 | 24.26 | 35.36 |
| | | | | | |
| PBITOE Margin (%) | 15.14 | 15.24 | 13.95 | 9.76 | 14.39 |
| PBTE Margin (%) | 15.65 | 15.98 | 15.05 | 10.27 | 15.70 |
| PBT Margin (%) | 15.39 | 15.98 | 14.72 | 10.27 | 15.90 |
| PAT Margin (%) | 10.39 | 11.05 | 10.57 | 7.76 | 11.88 |
| PAT After MI And SOA Margin (%) | 10.41 | 11.05 | 10.55 | 7.73 | 11.73 |